[Pathogenetic pharmacotherapy of erectile dysfunction].
Dorofeev
S D
SD
Paniushkin
S M
SM
Efremov
E A
EA
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology / Q000378:metabolism; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000378:metabolism; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism
D009569:Nitric Oxide; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human